The 2021 Annual Report of the Kansas Poison Control Center at The University of Kansas Health System
2021 KSPCC Annual Report
DOI:
https://doi.org/10.17161/kjm.vol16.19525Keywords:
poisoning, overdoseAbstract
Introduction. This is the 2021 Annual Report of the Kansas Poison Control Center (KSPCC) at The University of Kansas Health System. The KSPCC serves the state of Kansas 24-hours a day, 365 days a year with certified specialists in poison information and clinical and medical toxicologists.
Methods. Encounters reported to the KSPCC from 01/01/2021 through 12/31/2021 were analyzed. Data recorded includes caller demographics, exposure substance, nature and route of exposure, interventions, medical outcome, disposition, and location of care.
Results. The KSPCC logged 18,253 total encounters in 2021, including calls from every county in Kansas. A majority of human exposure cases (53.6%) were female. Approximately 59.8% were pediatric exposures (defined as 19 years of age or less). Most encounters occurred at a residence (91.7%) and most were managed there (70.5%). Unintentional exposures were the most common reason for exposures (70.5%). The most common reported substance in pediatric encounters was household cleaning products (n = 815) and cosmetics/personal care products (n = 735). For adult encounters, analgesics (n = 1,241) and sedative/hypnotics/antipsychotics (n = 1,013) were the most frequently reported. Medical outcomes were 26.0% no effect, 22.4% minor effect, 10.7% moderate effect, and 2.7% major effects. There were 22 deaths.
Conclusions. The 2021 KSPCC annual report demonstrated that cases were received from the entire state of Kansas. Pediatric exposures remained most common but cases with serious outcomes continue to increase. This report supports the continued value of the KSPCC to both public and health care providers in the state of Kansas.
Metrics
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Stephen L. Thornton, M.D., Lisa K. Oller, Pharm.D., Kathy White, R.N., Robert Stockdale, R.N., Elizabeth Silver, Pharm.D.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0).